跳至主要内容
临床试验/NCT07403305
NCT07403305尚未招募不适用

The Effect of Water Physical Exercise Program in Thermal Water and Hydropinotherapy on Cardiovascular Health

Instituto Politécnico de Bragança0 个研究点目标入组 80 人开始时间: 2026年1月19日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
80
主要终点
Lipid profile (total cholesterol, HDL-C, LDL-C, triglycerides)

研究概览

简要总结

The goal of this randomized four-arm clinical trial is to determine the effect of 16-week water physical exercise program in thermal water and hydroponotherapy on lipide profile in middle-aged and elderly people, with controlled health conditions.

Participants will be randomizate into four arms:

  • Arm I: Control
  • Arm II: Water Physical Exercise Program (WPEP) in thermal water
  • Arm III: Hydropinotherapy with thermal water combined with bay leaf (L. nobilis)
  • Arm IV: WPEP in thermal water and hydropinotherapy with thermal water combined with bay leaf (L. nobilis)

Primary outcome:

  1. Lipid profile (cholesterol total, low-density lipoprotein cholesterol (c-LDL), high-density lipoprotein cholesterol (c-HDL), triglycerides)

Secondary parameters: 2. Inflammatory biomarkers: interleukin-6 (IL-6), C-reactive protein (CRP) 3. Glucose metabolisc: fasting plasma glucose, insulin, Hemoglobin A1c (HbA1c) 4. Aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase, bilirubin, creatinine. 5. Anthropometric and clinical variables: weight, waist to hip ratio, body composition and bone mineral density 6. Systolic and diastolic blood pressure 7. Physical function 8. Lifestyle parameters: sleep quality, quality of life and eating habits

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
45 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men or women
  • Age: >45 years
  • Written informed consent prior to participation
  • Physical condition suitable for participating in physical exercise activities
  • Controlled health conditions

排除标准

  • History of chronic or severe diseases that may affect study outcomes or limit study participation, such as:
  • Decompensated cardiovascular disease, renal insufficiency, or severe liver disease
  • Conditions preventing the ability in physical activity (e.g., severe respiratory issues, reduced mobility, severe arthritis)
  • Severe psychiatric or cognitive disorders that could affect comprehension or adherence to the study
  • Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) or corticosteroids
  • Pregnancy or lactation
  • Less than 80% attendance at the 16-week aquatic exercise program

研究组 & 干预措施

Arm I: Control

No Intervention

Control

Arm II: WPEP in thermal water

Other

Water Physical Exercise Program in thermal water

干预措施: WPEP in thermal water (Behavioral)

Arm III: Hydropinotherapy

Other

Hydropinotherapy with thermal water combined with bay leaf (L. nobilis)

干预措施: Hydropinotherapy (Other)

Arm IV: WPEP in thermal water + Hydropinotherapy

Other

Water Physical Exercise Program in thermal water in thermal water and hydropinotherapy with thermal water combined with bay leaf (L. nobilis)

干预措施: Hydropinotherapy (Other)

Arm IV: WPEP in thermal water + Hydropinotherapy

Other

Water Physical Exercise Program in thermal water in thermal water and hydropinotherapy with thermal water combined with bay leaf (L. nobilis)

干预措施: WPEP in thermal water (Behavioral)

结局指标

主要结局

Lipid profile (total cholesterol, HDL-C, LDL-C, triglycerides)

时间窗: 16 weeks

Change in total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglyceride concentrations (mg/dL), measured by enzymatic spectrophotometry, with LDL-C calculated.

次要结局

  • Sleep quality(16 weeks)
  • Isokinetic muscle strength(16 weeks)
  • Health-related quality of life(16 weeks)
  • Pain intensity(16 weeks)
  • Psychosocial risk factors(16 weeks)
  • Total energy intake(16 weeks)
  • Macronutrient intake(16 weeks)
  • Hepatic enzymes(16 weeks)
  • Bilirubin(16 weeks)
  • Blood pressure(16 weeks)
  • Waist and hip circumferences(16 weeks)
  • Body composition(16 weeks)
  • Bone mineral density(16 weeks)
  • Maximal oxygen uptake (VO₂ max)(16 weeks)
  • Interleukin-6 (IL-6)(16 weeks)
  • C-reactive protein (CRP)(16 weeks)
  • Plasma Glucose(16 weeks)
  • Insulin(16 weeks)
  • Hemoglobin A1C (HbA1c)(16 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Anna Carolina Cortez Ribeiro

Principal Investigator

Instituto Politécnico de Bragança

相似试验